Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan

M T Nurmohamed, J Fareed, D Hoppensteadt, J M Walenga, J W ten Cate

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)205-13
Number of pages9
JournalSeminars in Thrombosis and Hemostasis
Volume17 Suppl 2
Publication statusPublished - 1991

Keywords

  • Animals
  • Anticoagulants/adverse effects
  • Blood Coagulation/drug effects
  • Cerebrovascular Disorders/drug therapy
  • Chondroitin Sulfates
  • Dermatan Sulfate
  • Drug Evaluation, Preclinical
  • Fibrinolytic Agents/pharmacology
  • Glycosaminoglycans/pharmacology
  • Hemorrhage/chemically induced
  • Heparin/therapeutic use
  • Heparitin Sulfate
  • Humans
  • Incidence
  • Mammals
  • Molecular Weight
  • Platelet Aggregation/drug effects
  • Postoperative Complications/prevention & control
  • Rabbits
  • Renal Dialysis
  • Thrombocytopenia/chemically induced
  • Thrombophlebitis/epidemiology
  • Thrombosis/drug therapy

Cite this